Genemod, a Seattle, WA-based provider of cloud-based workspace collaboration software for biopharma R&D teams, raised $4.5M in Seed funding.
The round was co-led by defy.vc and LDV Partners, with participation from Dolby Family Ventures and Vulcan/Cercano Ventures.
The company intends to use the funds to accelerate medicine discovery, development, and market access.
Led by CEO Jacob Lee and Jin Choe, Genemod is building a dynamic cloud-based research platform designed for research teams to house their entire R&D lifecycle: from data acquisition and project documentation to inventory management and reporting. The interface allows users to visualize their data and track progress and updates including what changes are made by whom.
In the past year, the company has expanded into the biopharma R&D space working with teams from startups to enterprise companies including AstraZeneca, Bristol-Myers, Merck, and more.
FinSMEs
04/05/2023